Patent · US Active

Transposon end compositions and methods for modifying nucleic acids

US9115396B2 · kind B2 · utility

24Cited by
54References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 2011
Grant dateAug 25, 2015
Priority date
Expiry dateJul 7, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2535/122
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compositions of transposome complexes for generating DNA fragments with specific 5′- and 3′-tags. Kits for generating libraries for sequencing, with transposome complexes, enzymes, oligonucleotides or other components.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.